전체 논문 (202편 · 1/7)
-
CSF-1R inhibition and lenalidomide synergize to promote myeloma control after autologous stem cell transplantation.
-
Immune thrombocytopenia in patients treated with immune checkpoint inhibitors.
-
International Expert Recommendations for the Diagnosis and Treatment of Malignant Histiocytic Neoplasms.
-
Neonatal Platelets Induce Monocytes to a Myeloid-Derived Suppressor Cell Phenotype.
-
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapies.
-
Mechanisms of immune escape and extramedullary tropism in leukemia cutis.
-
Fetal context conveys heritable protection against MLL-rearranged AML that depends on MLL3.
-
Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia.
-
Measurable residual disease intervention in AML: a new therapeutic horizon.
-
Fetal defense against leukemia: a developmental shield.
-
Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia.
-
Drug development in MZL: caring for the forgotten child.
-
Telomere content and genomics of myeloid neoplasia by whole-genome sequencing.
-
High-grade/large B-cell lymphoma-11q has a very good prognosis in children and young people without a predisposition.
-
Acute promyelocytic leukemia diagnosed on soft tissue biopsy: a rare extramedullary presentation.
-
Introduction to a review series on marginal zone lymphoma: reclaiming the afterthought.
-
PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study.
-
CPX-351 in Down syndrome-associated myeloid leukemia: results and prognostic factors from the phase 3 ML-DS 2018 trial.
-
Multiselective RAS(ON) inhibition targets oncogenic RAS and overcomes RAS-mediated resistance to FLT3i and BCL2i in AML.
-
PU.1-Activated Genomic Regions Define Low-risk MDS Subsets Characterized by Immune Dysregulation and Disease Progression.
-
DC-SIGN Binding to the Surface Ig Oligomannose-type Glycans Promotes Follicular Lymphoma Cell Adhesion and Survival.
-
How I treat chronic myeloid leukemia in children and adolescents.
-
The watch-and-wait approach for patients with juvenile myelomonocytic leukemia: results of the French cohort.
-
How I treat advanced phases of CML.
-
Introduction to a How I Treat series on chronic myeloid leukemia.
-
DHODH as a Targetable Metabolic Achilles' Heel for chemo-resistant B-ALL.
-
GATA1 N-terminus coordinates metabolic reprogramming in erythropoiesis.
-
Homeodomain-driven oncogenic diversion to a TCRγδ phenotype in T-cell Acute Lymphoblastic Leukemia.
-
High-Dimensional Spatiotemporal Single-Cell Atlas and 3D imaging of Bone Marrow Microenvironment during CML Progression.
-
The proteostasis network is a therapeutic target in acute myeloid leukemia.